Literature DB >> 27475325

The role of microRNAs in metabolic interactions between viruses and their hosts.

Megan H Powdrill1, Geneviève F Desrochers1, Ragunath Singaravelu2, John Paul Pezacki3.   

Abstract

Productive viral infection requires changes to the cellular metabolic landscape in order to obtain the building blocks and create the microenvironments necessary for the viral life cycle. In mammals, these alterations of metabolic pathways have been shown to be mediated in part by host and virus-encoded microRNAs. To counteract virally-induced changes in the cellular metabolic profile, the interferon-regulated antiviral response restricts viral access to key metabolites by altering cellular metabolism, mediated through induction of specific microRNAs regulating key lipid biosynthetic processes. In this review, we examine recent studies demonstrating the important role of microRNAs in the regulation of metabolic flux during viral infection.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27475325     DOI: 10.1016/j.coviro.2016.07.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  10 in total

1.  A conserved miRNA-183 cluster regulates the innate antiviral response.

Authors:  Ragunath Singaravelu; Nadine Ahmed; Curtis Quan; Prashanth Srinivasan; Christopher J Ablenas; Dominic G Roy; John Paul Pezacki
Journal:  J Biol Chem       Date:  2019-11-06       Impact factor: 5.157

2.  Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors.

Authors:  Gabriel Lutz; Igor Jurak; Eui Tae Kim; Ju Youn Kim; Michael Hackenberg; Andrew Leader; Michelle L Stoller; Donna M Fekete; Matthew D Weitzman; Donald M Coen; Angus C Wilson
Journal:  Viruses       Date:  2017-08-07       Impact factor: 5.048

3.  The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.

Authors:  Liming Jiang; Qiangming Sun
Journal:  Virol J       Date:  2018-03-22       Impact factor: 4.099

Review 4.  Recent Progress on Relevant microRNAs in Autism Spectrum Disorders.

Authors:  Xingwang Wu; Wanran Li; Yun Zheng
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

5.  miREM: an expectation-maximization approach for prioritizing miRNAs associated with gene-set.

Authors:  Luqman Hakim Abdul Hadi; Quy Xiao Xuan Lin; Tri Tran Minh; Marie Loh; Hong Kiat Ng; Agus Salim; Richie Soong; Touati Benoukraf
Journal:  BMC Bioinformatics       Date:  2018-08-10       Impact factor: 3.169

6.  Expression of miR-155 associated with Toll-like receptors 3, 7, and 9 transcription in the olfactory bulbs of cattle naturally infected with BHV5.

Authors:  Bruna R S M Oliveira; Flavia V Vieira; Dielson de S Vieira; Sergio E L da Silva; Roberto Gameiro; Eduardo F Flores; Tereza C Cardoso
Journal:  J Neurovirol       Date:  2017-08-22       Impact factor: 2.643

Review 7.  MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.

Authors:  Christine Hum; Julia Loiselle; Nadine Ahmed; Tyler A Shaw; Caroline Toudic; John Paul Pezacki
Journal:  Drugs       Date:  2021-02-27       Impact factor: 9.546

8.  Cytomegalovirus microRNAs level determination in kidney recipients post transplantation.

Authors:  Afsoon Afshari; Ramin Yaghobi; Mehdi Golshan
Journal:  Virol J       Date:  2022-09-12       Impact factor: 5.913

9.  piRNA Profiling of Dengue Virus Type 2-Infected Asian Tiger Mosquito and Midgut Tissues.

Authors:  Yanhai Wang; Binbin Jin; Peiwen Liu; Jing Li; Xiaoguang Chen; Jinbao Gu
Journal:  Viruses       Date:  2018-04-22       Impact factor: 5.048

10.  miR-142a-3p promotes the proliferation of porcine hemagglutinating encephalomyelitis virus by targeting Rab3a.

Authors:  Peng Fan; Jiyu Guan; Wenqi He; Xiaoling Lv; Shiyu Hu; Yungang Lan; Kui Zhao; Feng Gao; Fang Li; Gencheng Fan; Hongbin He; Zi Li
Journal:  Arch Virol       Date:  2019-12-13       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.